G. Weits
DisseminationInternet privacyInternal medicineIntensive care medicineProspective cohort studyData qualityTechnology acceptance modelEtanerceptSafety monitoringResponse rate (survey)DiseaseImmune-mediated inflammatory diseasesResearch designPharmacistMEDLINEDrugAdalimumabAdverse drug reactionTone (literature)Published ErratumIndependent researchOr educationMedical practiceTherapeutic decision makingDrug reactionPatient organizationIn patientMedical informationPharmacology toxicologyRheumatic diseaseFamily medicineSocial mediaClinical trialPharmacovigilanceMedicineCohortRelevance (information retrieval)Immune system
3Publications
0Citations
Publications 8
Newest
Patient-reported outcomes (PROs) on adverse drug reactions (ADRs) are increasingly used in cohort event monitoring (CEM) to obtain a better understanding of patients’ real-world experience with dru...
Source
Source
Patient-reported outcomes (PROs) are increasingly used in studies and medical practice to obtain information on patients’ perspectives towards their treatment or disease. However, most study outcom...
Source
#1Linda HärmarkH-Index: 14
#2Gerda WeitsH-Index: 1
Last. Florence van HunselH-Index: 15
view all 6 authors...
The article "Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands", written by Linda Harmark, Gerda Weits, Rietje Meijer, Federica Santoro, G. Niklas Noren, Florence van Hunsel, was originally published electronically on 16 May 2020 without open access.
Source
Background: Patient-reported outcomes (PROs) are increasingly used in studies and medical practice to obtain information on patients’ perspectives towards their treatment or disease. However, study outcomes are primarily directed at and shared with healthcare professionals, even though the results may also be relevant for patients. Objectives: The objective of this study was to obtain insight in which results patients with immune-mediated inflammatory diseases (IMIDs), including inflammatory rhe...
Source
#1Linda HärmarkH-Index: 14
#2Gerda WeitsH-Index: 1
Last. Florence van HunselH-Index: 15
view all 6 authors...
INTRODUCTION: To improve therapeutic decision making, it is crucial that information regarding adverse drug reactions reaches patients. It is not enough to disseminate such findings through regulatory and scientific channels; targeted efforts to reach patients are necessary. One possible avenue is to collaborate with patient organizations. OBJECTIVES: The aim of this pilot study was to explore how adverse drug reactions can be communicated through patient organizations. METHODS: A text describin...
Source
#1Gerda WeitsH-Index: 1
#2Linda HärmarkH-Index: 14
Last. Agnes KantH-Index: 2
view all 4 authors...
ABSTRACTBackground: Patient organizations have good access to patients, which can be of interest in gaining knowledge about patients’ experiences with drugs. The aim of this study is to investigate if a collaboration between a pharmacovigilance center and an ADHD patient organization can give more insight in patients’ experiences with drug use and ADRs for the treatment of AD(H)D.Methods: Pharmacovigilance Centre Lareb and ADHD patient organization Impuls & Woortblind created a web-based questio...
1 CitationsSource